Showing results (221-230 of 232) with videos related to

Sort By:
Pageof 24
Chemistry (Weinheim an Der Bergstrasse, Germany)|October 13, 2011
Aryl-aryl bond formation by the fluoride-free cross-coupling of aryldisiloxanes with aryl bromidesChristine M Boehner, Elizabeth C Frye, Kieron M G O'Connell, et al.
Chemical Society Reviews|December 8, 2020
Site-selective modification strategies in antibody-drug conjugatesStephen J Walsh, Jonathan D Bargh, Friederike M Dannheim, et al.
Organic & Biomolecular Chemistry|May 12, 2020
Diarylethene moiety as an enthalpy-entropy switch: photoisomerizable stapled peptides for modulating p53/MDM2 interactionAlexander V Strizhak, Oleg Babii, Sergii Afonin, et al.
Chemical Science|June 15, 2018
Stapled peptides as a new technology to investigate protein-protein interactions in human plateletsJessica Iegre, Niaz S Ahmed, Josephine S Gaynord, et al.
Scientific Reports|June 25, 2016
Allosteric modulation of AURKA kinase activity by a small-molecule inhibitor of its protein-protein interaction with TPX2Matej Janeček, Maxim Rossmann, Pooja Sharma, et al.
Chemical Science|October 3, 2017
Protein modification via alkyne hydrosilylation using a substoichiometric amount of ruthenium(ii) catalystTerence T-L Kwan, Omar Boutureira, Elizabeth C Frye, et al.
Current Topics in Medicinal Chemistry|April 8, 2011
Chemogenomics approaches for receptor deorphanization and extensions of the chemogenomics concept to phenotypic spaceEelke van der Horst, Julio E Peironcely, Gerard J P van Westen, et al.
ACS Chemical Biology|February 1, 2019
Toolbox of Diverse Linkers for Navigating the Cellular Efficacy Landscape of Stapled PeptidesYuteng Wu, Amandeep Kaur, Elaine Fowler, et al.
Journal of Medicinal Chemistry|August 27, 2024
Selective Aurora A-TPX2 Interaction Inhibitors Have In Vivo Efficacy as Targeted Antimitotic AgentsSimon R Stockwell, Duncan E Scott, Gerhard Fischer, et al.
Pageof 24